Company
PT Darya-Varia Laboratoria Tbk
Headquarters: Jakarta, Indonesia
Employees: 1,232
Market Cap
Rp1.781 Trillion
IDR as of July 1, 2025
US$110.1 Million
PT Darya-Varia Laboratoria Tbk Categories
Indonesia Healthcare Drug Manufacturers—Specialty & GenericIndonesia Healthcare Indonesia Drug Manufacturers—Specialty & Generic
Top Competitors by Market Capitalization
Industry: Drug Manufacturers—Specialty & Generic
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $699.59 B |
| Johnson & Johnson | $374.29 B |
| AbbVie | $336.94 B |
| Novo Nordisk | $309.91 B |
| UnitedHealth Group | $279.90 B |
Detailed Description
PT Darya-Varia Laboratoria Tbk engages in the manufacture and trading of pharmaceutical products and cosmetics in Indonesia and internationally. It operates in three segments: Prescription Drugs, Consumer Health Products, and Export and Toll Manufacturing Services. It provides various prescription and consumer health products in antibiotic, antiparasit, antiseptic, anti-fungal, cough and cold, cardiology, central nervous system, gastro-hepatology, somatic, vitamin and food supplement, women healthcare, ear healthcare, and derma medic areas. The company was founded in 1976 and is headquartered in Jakarta, Indonesia. PT Darya-Varia Laboratoria Tbk is a subsidiary of Blue Sphere Singapore Pte. Ltd.
Stocks & Indices
PT Darya-Varia Laboratoria Tbk has the following listings and related stock indices.
Stock: IDX: DVLA wb_incandescent